Things to note before using carbidopa/levodopa extended-release capsules

Carbidopa/levodopa extended-release capsules (carbidopa and levodopa) are a combination drug that has emerged in the field of treatment of Parkinson's disease and related symptoms. Parkinson's disease is a chronic degenerative disease of the nervous system. Patients often suffer from motor dysfunction, such as resting tremor, muscle stiffness, and bradykinesia. Not only that, the drug can also play a therapeutic role in Parkinson's syndrome caused by carbon monoxide poisoning or manganese poisoning.

Carbidopa/Levodopa may have effects on patients' mood and behavior, including depression, anxiety, panic attacks, sleep problems, impulsivity, irritability, agitation, aggression, talkativeness, and even thoughts of suicide or harming oneself. Patients and their families should closely observe these changes, and if any abnormalities are found, they should inform their doctors immediately so that the treatment plan can be adjusted in a timely manner.

Some patients may experience daytime drowsiness after taking carbidopa/L-dopa, or even fall asleep suddenly during normal activities (such as working or driving). Symptoms may appear for up to a year after taking the medication. Therefore, patients should avoid activities that require a high degree of concentration, such as driving or operating heavy machinery, while taking this medication. If daytime sleepiness is a serious problem, inform your doctor immediately.

Carbidopa/L-dopa sustained-release capsules have significant efficacy in the treatment of Parkinson's disease, but some side effects may occur during use. Mild side effectsIncluding uncontrolled muscle movements, dry mouth, anxiety, headache, dizziness, drop in blood pressure or feeling dizzy when standing, sleep problems (such as insomnia), strange dreams, muscle contractions, nausea, vomiting, and constipation. These symptoms usually appear at the beginning of medication and gradually decrease as the body adapts. If symptoms persist or worsen, you should consult your doctor promptly. Serious side effectsSuch as stomach bleeding (shown as bloody or tarry stools, coughing up blood, or vomiting similar to coffee grounds), allergic reactions (such as hives, difficulty breathing, swelling of the face or throat), uncontrolled muscle movements, blurred vision, eye pain or redness, severe nervous system reactions (such as muscle stiffness, high fever, confusion, abnormal heartbeat), etc. If the above symptoms occur, you need to seek medical attention immediately.

Carbidopa/levodopa extended-release capsules should be stored at 68°F to 77°F (20°C to 25°C< /span>) room temperature, with brief exposure to 59°F to 86°F (15°C to 30°C) environment. Medications need to be stored in a cool, dry place, keeping the container tightly closed, away from light and moisture. Patients should strictly follow the dosage and time prescribed by their doctor and avoid adjusting the dosage or stopping medication suddenly. During the medication period, regular follow-up visits are required to monitor drug efficacy and adverse reactions.

Carbidopa/L-dopa sustained-release capsules(carbidopa and levodopa)has been approved by the U.S. Food and Drug Administration on August 2024 It has been launched in the United States with the approval of the FDA. However, as the price information is not yet clear due to the launch time, patients in need can pay attention to the official website of the FDA or relevant medical news to obtain the latest updates. Patients in urgent need of medication can contact regular overseas medical consultation agencies.

Reference link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217186s000lbl.pdf